Health Blueprint

Back to Longevity News

News summary

Biodelphis Therapeutics, PolaSight and Swiss Soil get FIT backing

Source: Startupticker.ch • Published: 28 Oct 2026, 00:00

Summarized by Masters of Longevity from Startupticker.ch.

FIT granted equal Tech Seed loans to three startups for product development.

Biodelphis Therapeutics, PolaSight and Swiss Soil get FIT backing
Key Takeaways
  • Biodelphis was funded to advance an osteoporosis treatment.
  • PolaSight was funded to prepare its intraoperative tissue scanner.
  • Swiss Soil was funded to run vineyard system field trials.
Read the full article at Startupticker.ch ↗

Continue exploring

Recommended MoL Picks

MoL PickSeed Oils and Health: Inflammation, Processing and EvidenceHuman trials, processing risks and long-term health ask different questions. What can seed-oil research tell us—and what remains unresolved?MoL PickThe Next Obesity-Drug Race Is About What Weight You LoseRegeneron’s myostatin and activin A antibodies point to a sharper question for the GLP-1 era: not whether people can lose more weight, but whether medicine can preserve the tissue that makes weight loss healthier.MoL PickPlan Your Health Tests in Three MinutesThe free Personal Health Diagnostics Planner turns a short questionnaire into a ranked, personalised PDF: a clearer starting point for deciding which health checks deserve attention now.